Butamben derivatives enhance BMP-2-stimulated commitment of C2C12 cells into osteoblasts with induction of voltage-gated potassium channel expression.
Hye Joo Kim, Mikyung Park, Young-Min Han, Byoung-Mog Kwon, Seong Hwan Kim
Index: Bioorg. Med. Chem. Lett. 21 , 7363-6, (2011)
Full Text: HTML
Abstract
As the primary step for 'drug repositioning', we evaluated the effect of 2000 drugs and drug candidates on the commitment of bi-potential mesenchymal precursor C2C12 cells into osteoblasts in the presence of bone morphogenetic protein (BMP)-2 and found that butamben enhanced BMP-2-stimulated induction of alkaline phosphatase, a biomarker of osteoblastogenesis. Investigating the underlying mechanism of its anabolic actions, we found anabolic action of its derivative (compound 4) relies on BMP-2 signaling and mRNA induction of BMPs and voltage-gated potassium channels.Copyright © 2011 Elsevier Ltd. All rights reserved.
Related Compounds
Related Articles:
Tumor-preferential sustained drug release enhances antitumor activity of block copolymer micelles.
2014-08-01
[J. Drug Target. 22(7) , 619-28, (2014)]
1996-05-01
[J. Pharm. Biomed. Anal. 14(7) , 765-71, (1996)]
In Silico Estimation of Skin Concentration Following the Dermal Exposure to Chemicals.
2015-12-01
[Pharm. Res. 32 , 3965-74, (2015)]
2002-08-22
[Org. Lett. 4(17) , 2913-6, (2002)]
Efficient preparation of nitrosoarenes for the synthesis of azobenzenes.
2005-03-18
[J. Org. Chem. 70(6) , 2350-2, (2005)]